Viatris Inc. (VTRS)

Sector:Health Care
Super Investor Stats:
Ownership count:4
Ownership rank:131
% of all portfolios:0.149%
Hold Price * :$10.63
History Portfolio Manager Activity Share change % change to portfolio
Q2  2024
Kahn Brothers Group Reduce 57.86% 19,435 0.04
Q1  2024
Christopher Davis - Davis Advisors Reduce 8.29% 5,196,329 0.35
Bill Miller - Miller Value Partners Reduce 13.00% 92,500 0.76
Kahn Brothers Group Reduce 35.84% 18,766 0.03
Q4  2023
Christopher Davis - Davis Advisors Reduce 2.19% 1,402,057 0.09
Kahn Brothers Group Reduce 24.11% 16,632 0.03
Q3  2023
Kahn Brothers Group Reduce 3.89% 2,794 0.00
Bill Miller - Miller Value Partners Reduce 13.81% 114,000 0.72
Q2  2023
Kahn Brothers Group Reduce 2.52% 1,855 0.00
Bill Miller - Miller Value Partners Reduce 6.56% 58,000 0.39
Q1  2023
Kahn Brothers Group Reduce 0.72% 537 0.00
Bill Miller - Miller Value Partners Reduce 6.36% 60,000 0.04
Q4  2022
Kahn Brothers Group Reduce 0.39% 288 0.00
Christopher Davis - Davis Advisors Reduce 1.33% 738,579 0.06
Q3  2022
Christopher Davis - Davis Advisors Reduce 0.01% 5,961 0.00
Kahn Brothers Group Reduce 0.99% 747 0.00
Bill Miller - Miller Value Partners Reduce 3.48% 34,000 0.02
Q2  2022
Christopher Davis - Davis Advisors Reduce 2.12% 1,200,143 0.08
Kahn Brothers Group Reduce 13.31% 11,551 0.02
Q1  2022
Kahn Brothers Group Reduce 1.72% 1,520 0.00
Q4  2021
Lee Ainslie - Maverick Capital Sell 100.00% 27,790 0.00
Q3  2021
Kahn Brothers Group Reduce 3.83% 3,508 0.01
Q2  2021
Kahn Brothers Group Reduce 0.54% 493 0.00
Richard Pzena - Hancock Classic Value Sell 100.00% 1,014,110 0.64
Q1  2021
Kahn Brothers Group Reduce 1.64% 1,533 0.00
Lee Ainslie - Maverick Capital Sell 100.00% 85,771 0.03

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.